Sky Century Investment (SKYI) Other Non Operating Income (2024 - 2025)
Sky Century Investment (SKYI) posted quarterly Other Non Operating Income of -$81.0 for Q1 2025, up 84.21% quarter-over-quarter from -$513.0 in Q4 2024.
Sky Century Investment (SKYI) Other Non Operating Income (2024 - 2025) Analysis & Trends
Sky Century Investment (SKYI) has reported Other Non Operating Income for 2 consecutive years, with -$81.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Non Operating Income changed N/A year-over-year to -$81.0; the TTM figure through Nov 2025 stood at -$81.0 (up 84.21% YoY), while the FY2025 annual figure was -$594.0, changed N/A from the prior year.
- Other Non Operating Income advanced to -$81.0 in Q1 2025 per SKYI's latest filing, from -$513.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $12000.0 in Q2 2024 and bottomed at -$12000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2025 | -81.00 |
| Nov 30, 2024 | -513.00 |
| Aug 31, 2024 | -12,000.00 |
| May 31, 2024 | 12,000.00 |